Taiwan medical societies oppose use of Propofol for insomnia

Three major medical organizations in Taiwan, including the Taiwan Society of Anesthesiologists, the Taiwan Society of Psychiatry, and the Taiwan Society of Addiction Medicine, have issued a joint statement opposing the use of Propofol, commonly known as “milk injections,” to treat insomnia or depression.

The societies warned that Propofol is a controlled anesthetic intended for general anesthesia or sedation during medical procedures, not for sleep aid. They emphasized that the drug carries significant risks, including respiratory depression, hypotension, and life-threatening cardiovascular abnormalities. Misuse can lead to addiction and fatal consequences, citing the death of Michael Jackson as a cautionary example.

The controversy follows allegations that a clinic in New Taipei City has been administering the drug to patients for long-term insomnia treatment, leading to physical and mental health issues. Taiwan’s Minister of Health and Welfare, Shih Chung-liang, stated that Propofol is not a routine medication for insomnia and noted that such practices may violate medical laws. The Ministry of Health and Welfare is considering a comprehensive inspection of relevant clinics.